| JYSB2300196 | 甘精胰岛素利司那肽注射液（Ⅱ） | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Supplementary Application | 2023-11-11 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JTH2200023 | L-iso-Asp(28)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2022-02-17 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2400100 | 甘精胰岛素利司那肽注射液（Ⅱ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-05-06 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYHB2300468 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYHZ2100675 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2300205 | 利司那肽 | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2023-08-26 | | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JTH2200052 | Des-[His(1)-Gly(2)]-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2022-03-11 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2400030 | Di-Ala(35)-利司那肽 | | Other | Chemical Drugs | Disposable Import Drug Application | 2024-03-01 | | EUROAPI Germany GmbH;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JXSL2101131 | 甘精胰岛素利司那肽注射液1:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-11-17 | | Sanofi KK;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2400174 | 甘精胰岛素利司那肽注射液（Ⅱ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-08-09 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYHB2300467 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | Sanofi-Aventis Deutschland GmbH;Sanofi Winthrop Industrie | | | view |
| JYHZ2100677 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2400029 | 利司那肽（TFA-SSS） | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2024-03-01 | | EUROAPI Germany GmbH;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2100626 | 利司那肽 | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2021-08-19 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JXSS2101025 | 甘精胰岛素利司那肽注射液2:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-30 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2300204 | Di-Ser(33)-利司那肽 | | Other | Chemical Drugs | Disposable Import Drug Application | 2023-08-26 | | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JTH2200026 | Iso-Asp(9)- 利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2022-02-17 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTH2400032 | Di-Ser(33)-利司那肽 | | Other | Chemical Drugs | Disposable Import Drug Application | 2024-03-01 | | EUROAPI Germany GmbH;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JYHZ2100676 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | Sanofi-Aventis Groupe;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2400173 | 甘精胰岛素利司那肽注射液（Ⅰ） | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-08-09 | | Sanofi KK;Sanofi-Aventis Deutschland GmbH | | | view |
